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LETTER TO THE EDITOR
Creatinine and cystatin C: Shooting at a ﬂying target
CHIA-TER CHAO
Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine,
National Taiwan University, Taipei, Taiwan
Dear Sir,
I read with great interest the article entitled
‘Signiﬁcant differences when using creatinine, mod-
iﬁcation of diet in renal disease, or cystatin C for
estimating glomerular ﬁltration rate in ICU patients’
by Lipcsey et al. (1) in the March 2011 issue of the
Upsala Journal of Medical Sciences. This article pro-
vides an interesting analysis of estimating renal func-
tion in critically ill patients, but I believe there are
several aspects that may warrant further discussion:
First of all, the equations estimating glomerular
ﬁltration rate (GFR) are all notoriously ﬂawed in
the setting of rapidly changing renal function, that
is, acute kidney injury. The creatinine-based formula
for creatinine clearance is shown to over-estimate
renal function when actual GFR is low, due to its
multiple interfering factors and tubular secretion
nature, but the cystatin C-based formula is also
affected by muscle mass and adiposity (2). To com-
plicate things further, serum cystatin C level is con-
founded by inﬂammation status and corticosteroid
use, both of which are frequently found in patients
under critical care (3). With this in mind, we can
presume that both formulae will not sufﬁce as good
estimators of renal function in critically ill patients
with acute kidney injury, especially when patients are
admitted with relative adrenal insufﬁciency or septic
shock status.
Second, the duration of illnesses and timing of tests
are also not taken into consideration in Lipcsey’s
article. Nejat et al. in their multicenter observation
study have indicated that cystatin C rises earlier than
creatinine in patients with acute kidney injury by 4–
5 hours from a general ICU population (4). Herget-
Rosenthal et al. also demonstrated a lag time, on
average one-and-a-half days, between cystatin C ele-
vation and creatinine to the same level (5). In this
sense, the signiﬁcantdifference between cystatinC and
creatinine-estimated GFR in Lipcsey's results will be
prominently inﬂuenced by the timing of blood tests. If
intensivists elect to check renal markers earlier in the
course of disease by hours or days, they will undoubt-
edly discover a sharp difference between actual and
estimated renal function, while later tests will not. This
is also reﬂected in the study by Endre et al., in which a
biomarker for acute kidney injury achieves better
predictability of outcome when it is tested earlier (6).
Finally, is there any better way of determining renal
function in the critically ill with convenient point-of-
care feasibility? Tidman et al. in their study of GFR
determination in chronic kidney disease patients have
provided a new thought: combining creatinine-
based and cystatin C-based results for estimation
(7). Though this study focuses on patients with stable
renal function, it may be worthwhile to extrapolate
this ﬁnding to the critically ill ones. To target ﬂying
objects, we need to trace more accurately their path
and take it with one shot.
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